Macrophages from patients with cirrhotic ascites showed function alteration of host defense receptor

Abdel Motaal M Ahmed1, Abdel Gadir Y Kadaru2, Ibtihal Omer3

  • 1Department of Medicine, The National University for Medical and Allied Sciences, Khartoum 11123, Sudan.

Abstract

Insights

Patients with cirrhotic ascites have impaired macrophage phagocytosis, but this function improves after IL-4 treatment, suggesting potential therapeutic avenues for spontaneous bacterial peritonitis.

Area of Science:

  • Immunology
  • Gastroenterology
  • Cell Biology

Background:

  • Patients with cirrhotic ascites (PCA) are at high risk for spontaneous bacterial peritonitis (SBP), a serious complication.
  • Altered functions of peritoneal macrophages (PMɸ) in PCA may contribute to increased infection susceptibility.

Purpose of the Study:

  • To investigate factors related to receptor-mediated phagocytosis in peritoneal macrophages from patients with cirrhotic ascites.
  • To assess the role of the mannose receptor (MR) and IL-4 in macrophage phagocytic activity.

Main Methods:

  • Peritoneal macrophages (PMɸ) were isolated from ascitic fluid of 12 PCA patients.
  • Phagocytosis of mannose receptor ligand and yeast particles was measured pre- and post-IL-4 treatment.
  • MRC1 gene expression was analyzed using PCR.

Main Results:

  • PCA patients' PMɸ showed significantly lower uptake of MR-specific ligand compared to controls.
  • IL-4 treatment enhanced phagocytosis in PCA patients' PMɸ.
  • MRC1 gene was not detected in PCA patients, unlike controls.

Conclusions:

  • Decreased phagocytosis and MR uptake in PCA patients may be due to MR downregulation, which is reversible with IL-4.
  • The absence of MRC1 gene expression warrants further investigation.
  • These findings highlight altered host defense mechanisms relevant to SBP pathophysiology in PCA.

Related Concept Videos